Selected article for: "antibody induction and protective immunity"

Author: Curtiss, Roy
Title: Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
  • Cord-id: xa6km2ev
  • Document date: 2015_3_13
  • ID: xa6km2ev
    Snippet: This chapter reviews papers mostly written since 2005 that report results using live attenuated bacterial vectors to deliver after administration through mucosal surfaces, protective antigens, and DNA vaccines, encoding protective antigens to induce immune responses and/or protective immunity to pathogens that colonize on or invade through mucosal surfaces. Papers that report use of such vaccine vector systems for parenteral vaccination or to deal with nonmucosal pathogens or do not address indu
    Document: This chapter reviews papers mostly written since 2005 that report results using live attenuated bacterial vectors to deliver after administration through mucosal surfaces, protective antigens, and DNA vaccines, encoding protective antigens to induce immune responses and/or protective immunity to pathogens that colonize on or invade through mucosal surfaces. Papers that report use of such vaccine vector systems for parenteral vaccination or to deal with nonmucosal pathogens or do not address induction of mucosal antibody and/or cellular immune responses are not reviewed.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and additional consideration: 1
    • acute respiratory syndrome and additional mean: 1, 2, 3
    • acute respiratory syndrome and additional perspective: 1, 2
    • acute respiratory syndrome and additional time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory syndrome and address infectious disease: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adequately address: 1, 2, 3, 4
    • acute respiratory syndrome and adequately study: 1
    • acute respiratory syndrome and adjuvant activity: 1, 2
    • acute respiratory syndrome and adjuvant effect: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adjuvant form: 1, 2
    • acute respiratory syndrome and adjuvant strain: 1
    • acute respiratory syndrome and administer vaccine: 1
    • acute respiratory syndrome and administration time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
    • acute respiratory syndrome and live bacterial vector: 1
    • acute respiratory syndrome and live polio vaccine: 1
    • acute respiratory syndrome and live vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
    • acute respiratory syndrome and liver delivery: 1, 2, 3, 4
    • acute respiratory syndrome and long persist: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13